Shandong Weigao Buys Connected Party Industrial Land Use Right in Weihai

The latest announcement is out from Shandong Weigao Group Medical Polymer Co ( (HK:1066) ).

Shandong Weigao Group Medical Polymer Company Limited has agreed to acquire the land use right for an industrial plot in Weihai City, Shandong Province, from its connected party Weigao Biotechnology for RMB39.71 million. The land, measuring about 76,342 square meters in the Torch Hi-tech Industrial Development Zone and designated for industrial use until April 14, 2070, was originally obtained by Weigao Biotechnology in 2020 for RMB25.3 million.

Because Weigao Biotechnology is indirectly controlled by Shandong Weigao’s controlling shareholder, the deal is classified as a connected transaction under Hong Kong Listing Rules but falls within the lower threshold that requires reporting and public announcement only, without independent shareholders’ approval. The acquisition consolidates land resources within the group and may support future expansion of Shandong Weigao’s manufacturing capacity in a key high-tech industrial hub, while signaling active internal asset reallocation under regulatory oversight.

The most recent analyst rating on (HK:1066) stock is a Hold with a HK$5.50 price target. To see the full list of analyst forecasts on Shandong Weigao Group Medical Polymer Co stock, see the HK:1066 Stock Forecast page.

More about Shandong Weigao Group Medical Polymer Co

Shandong Weigao Group Medical Polymer Company Limited is a Chinese medical device manufacturer focused on polymer-based medical products, serving hospitals and healthcare markets. Listed in Hong Kong, the company operates within the broader medical technology and healthcare supply industry, with facilities concentrated in Shandong Province and other key industrial zones in China.

Average Trading Volume: 15,774,087

Technical Sentiment Signal: Sell

Current Market Cap: HK$20.08B

See more insights into 1066 stock on TipRanks’ Stock Analysis page.